Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound

Bykov, Vladimir J.N., Issaeva, Natalia, Shilov, Alexandre, Hultcrantz, Monica, Pugacheva, Elena, Chumakov, Peter, Bergman, Jan, Wiman, Klas G. +1 more·2002·Nature Medicine
DOI 10.1038/nm0302-282

Cited by (1,000)

Items 901–1,000 of 1,000

  1. Wild-Type p53 Protein Enhances APR-246-Induced Cytotoxicity in Acute Myeloid Leukemia and Normal Hematopoietic Stem/Progenitor Cells
    John Bradley Cart, David Zhu, Lucas Norris, Sadhna O. Piryani, Li-Chan Chang, Christine Elissa Eyler, Chang‐Lung Lee · 2026 · International Journal of Molecular Sciences
  2. Drugging p53 mutants: Recent advances using small-molecule modulation strategies
    Elizabeth A. Lopes, Tomás G. Monteiro, Maria M. M. Santos · 2026 · European Journal of Medicinal Chemistry
  3. Mutant p53 reactivation and DNA demethylation in the treatment of AML/MDS
    Huaxin Song, Xinjie Chen, Shujun Xiao, Jiaqi Wu, Yuting Dai, Wen Wu, Yu Wu, 翁香勤, Jiachun Song, Ni Yan et al. · 2026 · Science Translational Medicine
  4. Molecular Pathology of the Genitourinary Tract: Prostate and Bladder
    Sahussapont Joseph Sirintrapun, Anil Vasdev Parwani · 2008 · Surgical pathology clinics
  5. A Novel c-kit Positive Biphenotypic Acute Leukemia Cell Line, TMBL-1, Carrying a p53 Point Mutation
    Shinsuke Suzuki, Kimiharu Uozumi, Shuichi Hanada, Xiaoyan Lin, Nobuhito Ohno, Yoshifusa Takatsuka, Syogo Takeuchi, Satsuki Owatari, Taketsugu Takeshita, Terukatsu Arima · 2003 · Leukemia & lymphoma/Leukemia and lymphoma
  6. Overexpression of the Novel Tumor Suppressor Gene FUS1 Suppresses the Growth of Small Cell Lung Cancer Cells
    Kai Xu Hans S. Poulsen · 2011 · Journal of Clinical & Experimental Pathology
  7. Apoptosis Pathways and Chemotherapy
    Jörg Steinbach, Michael Weller · 2006 · Elsevier eBooks
  8. Exploiting Senescence for Cancer Treatment
    Mayur A. Gadhikar, Pankaj Kumar Singh · 2016 · Molecular Biology
  9. Targeting apoptosis is the major battle field for killing cancers
    Xiaochun Liu · 2015 · World Journal of Translational Medicine
  10. Small molecules targeting misfolded mutants of p53 as a rescue strategy to improve glioblastoma chemotherapy
    Arutselvan Natarajan, Husam A. Babikir, Ramasamy Paulmurugan, Tarik F. Massoud · 2021 · Elsevier eBooks
  11. Research Progress of Mutant p53 as a Potential Therapeutic Target for Breast Cancer
    俊臻 周 · 2021 · Advances in Clinical Medicine
  12. PRIMA-1MET Does Not Restore Vitamin D Sensitivity to MDA-MB-231 and MDA-MB-468 Triple-Negative Breast Cancer Cells
    Shadi N. Kotob, Jessica L. Kelts · 2023 · ACS Omega
  13. Modulation of Autophagy and Apoptosis in Leukemia
    Laura Della Torre, Antonio Beato, Vincenza Capone, Daniela Carannante, Giulia Verrilli, Gregorio Favale, Hoda Taherigorji, Minha Naseer, Lucia Altucci, Rosaria Benedetti et al. · 2023 · Elsevier eBooks
  14. Apoptosis as a therapeutic strategy for breast cancer: the role of Thymax, a gross thymic extract, in modulating cell death pathways
    Amany Elwakkad, Amina A. Gamal el Din, Mohamed A. Hebishy, Howida S. Abou-Seif · 2024 · Egyptian Pharmaceutical Journal
  15. Transcriptional Activation by p53: Mechanisms and Targeted Genes
    Timothy K. MacLachlan, Wafik S. El‐Deiry · 2007 · Springer eBooks
  16. Genetische Grundlagen der Kanzerogenese
    Claus Rainer Bartram · 2009 · Springer eBooks
  17. Future Developments: Novel Agents
    Chong Chyn Chua, Andrew H. Wei · 2021 · Hematologic malignancies
  18. Carcinogenesis and cancer prevention: the process and the disease deserve a better understanding.
    Gopala K. Kovvali · 2002 · Journal of Carcinogenesis
  19. Apoptose-Mechanismen in der Onkogenese von Hauttumoren
    M. Leverkus · 2008 · Aktuelle Dermatologie
  20. The p53 Transcription Factor as Therapeutic Target in Cancer
    Charlotte Asker, Vladimir J.N. Bykov, Cristina Méndez‐Vidal, Galina Selivanova, Margareta Wilhelm, Klas G. Wiman · 2004 · Handbook of experimental pharmacology
  21. Loss of mutant TP53 does not impair the sustained proliferation, survival or metastasis of diverse cancer cells
    Zilu Wang, François Vaillant, Catherine W.T. Chang, Chris D. Riffkin, Elizabeth Lieschke, Sarah T. Diepstraten, David C.S. Huang, Jane E. Visvader, Marco J. Herold, Gemma L. Kelly et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Exploring and Restoring the p53 Pathway Using the p53 Dissociator Assay in Yeast
    Rainer Karl Brachmann · 2007 · Springer eBooks
  23. Apoptosis Induction for Cancer Therapy
    Edwin Bremer, Wijnand Helfrich · 2011 · Springer eBooks
  24. Cancer Therapy by Reactivation of the p53 Apoptosis Pathway
    Hélène Stridh, Vladimir J.N. Bykov, Galina Selivanova, Klas G. Wiman · 2006 · Wiley eBooks
  25. Genetische Grundlagen der Kanzerogenese
    Claus Rainer Bartram · 2004 · Springer eBooks
  26. WHO and six publishers launch Access to Research, internet initiative for developing countries
    2002 · Annals of Oncology
  27. p53 restoration
    Kristine D. Novak · 2002 · Nature reviews. Cancer
  28. Genomic Mutation as A Potential Driver of The Development of Bone-Related Cancers
    Sun H. Park, Yusuke Shiozawa · 2019 · Elsevier eBooks
  29. The biological and prognostic role of long non-coding RNA NEAT1 in acute myeloid leukemia
    Sophia Miliara, Anne Neddermeyer, Alessandro Bonetti, Jay W. Shin, Huthayfa Mujahed, Piero Carninci, Erik Arner, Lehmann Soren, Andreas Lennartsson · 2022 · Research Square
  30. Unraveling the Complex Pathology of Neurodegenerative Diseases: Multiple Prions, Cross-β Networks and Baicalein's ReproFold
    Hsiang‐Yu Chang, I‐Fan Wang · 2024 · Preprints.org
  31. Understanding the Effects of Cancer-Associated Mutations in the Tumor Suppressor Protein p53: Structural Consequences of Mutations and Possible Ways of Rescuing Oncogenic Mutants
    Andreas C. Joerger, Assaf Friedler, Alan Roy Fersht · 2007 · Springer eBooks
  32. Recherche bioguidée de molécules anticancéreuses issues de microalgues marines
    Virginie Pasquet · 2011
  33. p53 in Head and Neck Cancer
    Jong-Lyel Roh, Wayne M. Koch · 2014 · Springer eBooks
  34. Die Tumorbiologie von Kopf-Hals-Tumoren
    Ingeborg Tinhofer-Keilholz · 2014 · Der Onkologe
  35. A Novel Assay for the Quantification of Active Transcription Factors
    Isabel M. Goodhand · 2011 · UPT. Syiah Kuala University Library (Syiah Kuala University)
  36. HPV and Radiation Sensitivity
    Anna-Maria De Costa, Thorsten Rieckmann, Randall J. Kimple · 2015 · Springer eBooks
  37. Apoptosis: Regulatory Genes and Disease
    Leonhard Müllauer, Sabine Wohlfart, Brigitte Scheucher · 2006 · Encyclopedia of Life Sciences
  38. Role of integrin signaling in cell proliferation and survival
    Wenjie Bao · 2005 · Figshare
  39. E2F1 induction following DNA damage and oncogene activation
    G. Vignir Helgason · 2007 · Enlighten: Theses (The University of Glasgow)
  40. Small Molecules as Research Tools for Studying the Biology of the Tumour Suppressor p53
    Clemens Spinnler · 2011 · Figshare
  41. Multiple modes of Mdmx regulation affect p53 activation
    Daniele M. Gilkes · 2008 · Digital Commons - University of South Florida (University of South Florida)
  42. Proteomic analysis of DNA damage induced stress signaling with focus on p53 : S100A6 regulation, function and potential as biomarker in lung cancer and as a novel therapeutic target
    Lukas M. Orre · 2008 · Figshare
  43. Modulation of p53 activities by the prolyl-isomerase PIN1 and the bromodomain protein BRD7
    Francesca Tocco · 2008 · OpenstarTs (Univeristy of Trieste https://www.units.it/)
  44. Effect of MMR status and growth rate of colon carcinoma cells in response to 5-fluorouracil
    Choudhary, Bhavesh · 2011 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  45. The role of the Homeobox gene HOXD10 in Lung and Head & Neck carcinoma
    Fahad Hakami · 2013 · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
  46. Estabelecimento de linhagens tumorais para estudos in vitro e in vivo de carcinoma urotelial da bexiga e adenocarcinoma de próstata
    Camila Belfort Piantino · 2009
  47. To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration
    Grzegorz Sarek · 2010 · Työväentutkimus Vuosikirja
  48. TP53 mutations in myelodysplastic syndromes with deletion of 5q
    Leonie Saft · 2013 · Figshare
  49. The Role of p53 in Cetuximab Induced Radiosensitization of A549 Cells and the Mechanisms Involved
    Fabian Morsbach · 2014
  50. Apoptotic signaling in lung carcinoma cells : With focus on mechanisms of radioresistance
    Jessica Ekedahl · 2003 · Figshare
  51. Molecular genetic studies on Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia - with focus on prognostic markers
    Kerstin Willander · 2014 · Linköping University Electronic Press eBooks
  52. Targeting of the Myc pathway as a novel approach for cancer therapy
    Hao Mo · 2006 · Figshare
  53. Análise do efeito do Prima-1 na expressão dos genes envolvidos na morte celular programada em linhagens de câncer de bexiga
    Camila Belfort Piantino · 2012
  54. Mechanisms of p53-mediated intrinsic and extrinsic tumor suppression
    Hai Li · 2014 · Figshare
  55. Inhibition of Erythroleukemia Cell Growth by Triplex-forming RNAs.
    Richard N. Ré, Zhuo Zhang, Julia L. Cook · 2007 · PubMed Central
  56. Apoptosis signaling in leukemia and lymphoma: understanding mechanisms of chemoresistance
    Astrid Ottosson Wadlund · 2011 · Figshare
  57. Modulation of p53's transcriptional function by small molecules
    Fedor Nikulenkov · 2011 · Figshare
  58. PHARMACOLOGICAL TARGETING OF P53 PATHWAY ALTERATIONS IN TUMORS
    Ying Zhao · 2010 · Figshare
  59. Restoring p53 Function: Novel Anticancer Approaches for an Old Foe
    2012 · BENTHAM SCIENCE PUBLISHERS eBooks
  60. TP53: A master gene in normal and tumor suppression
    Pierre L. Hainaut · 2007 · Cambridge University Press eBooks
  61. Studies of mutant p53-targeting small molecules
    Nicole Zache · 2007 · Figshare
  62. Induction of apoptosis promoted by Bang52; a small molecule that downregulates Bcl-xL
    Matteo Rossi, Jeong-kyu Bang, Sharlyn J. Mazur, Jaclyn A. Iera, Darren C. Phillips, Gerard P. Zambetti, Daniel H. Appella · 2009 · Bioorganic & Medicinal Chemistry Letters
  63. STEPping into Position: A New Player in the NMDA Receptor Game
    Isabelle M. Mansuy · 2002 · Molecular Interventions
  64. DISSECTING THE P53 PATHWAY BY MEANS OF SMALL MOLECULE- MEDIATED REACTIVATION AND COMPUTATIONAL BIOLOGY
    Martin Enge · 2009 · Figshare
  65. Teaching cancer cells to die
    Leigh S. Zawel · 2004 · Journal of Cellular Biochemistry
  66. Roles of Myc and Mad in cell cycle and apoptosis
    Ami Albihn · 2006 · Figshare
  67. Hamlet; A Novel Tool to Identify Apoptotic Pathways in Tumor Cells
    Caroline Düringer, Oskar Hällgren, Lotta Gustafsson, Jenny Pettersson-Kastberg, Ann‐Kristin Mossberg, Taras Manilov, Catharina Svanborg · 2005 · Springer eBooks
  68. Molecular Biology of Urothelial Cancer
    Sounak Gupta, Donna Elizabeth Hansel · 2014 · Springer eBooks
  69. DNA damage-induced cell death : The role of caspase-2
    Helin Vakifahmetoglu · 2009 · Figshare
  70. Pharmacological targeting of mutant p53 family members
    Nina Rökaeus · 2011 · Figshare
  71. Mutacje TP53 w nowotworach hematologicznych
    M Zajac, Krzysztof Giannopoulos · 2015 · Acta Haematologica Polonica
  72. CDK inhibitor VMY-1-103 causes cell cycle arrest and apoptosis in cancer cell lines
    Lymor Ringer · 2012 · DigitalGeorgetown (Georgetown University Library)
  73. Análise do efeito do Prima-1 na expressão dos genes envolvidos na morte celular programada em linhagens de câncer de bexiga
    São Paulo · 2012
  74. Targeting Mutant p53 for Improved Cancer Therapy
    Jinfeng Shen, Vladimir J.N. Bykov, Klas G. Wiman · 2012 · Springer eBooks
  75. Aberrations of DNA Damage in Checkpoints in Cancer
    Marikki Laiho · 2007 · Humana Press eBooks
  76. Molecular Mechanisms of Reovirus Oncolysis
    Da Pan · 2013 · Library and Archives Canada (Government of Canada)
  77. Expression of c-erbB2 andp53in Curatively Resected Gastric Cancer: Correlation with Clinicopathologic Features and Prognosis
    Hoon Hur, Jeong Min Yi, In Kyu Lee, Kyo Young Song, Wook Kim, Cho Hyun Park, Hae Myung Jeon · 2011 · Journal of the Korean Surgical Society
  78. Mechanisms of p53-mediated Intrinsic and Extrinsic Tumor Suppression
    Galina Selivanova, Petter Höglund, Giulia Piaggio, Regina Elena, Teresa Pereira, Anthony R. Wright, Claes Wadelius, Uppusala Universitit · 2014
  79. Molecular Insights into the Regulation of Apoptosis and Cellular Senescence and Their Implications for Cancer
    Yoshikazu Johmura, Makoto Nakanishi · 2016 · Springer eBooks
  80. DRUG RESISTANCE IN ACUTE MYELOID LEUKEMIA
    Bertil Uggla · 2008
  81. Therapeutic Approaches to Modulation of Cell Death (non-HIV)
    Dara Ditsworth, Rebecca Elstrom, Craig B. Thompson · 2005 · CRC Press eBooks
  82. ID4 Acts as a Tumor Suppressor via p53: Mechanistic Insight
    Morton, Jeremy P. Derrick · 2016 · Atlanta University Center Robert W. Woodruff Library (Atlanta University Center Robert W. Woodruff Library)
  83. Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins
    2016 · Frontiers research topics
  84. Investigation of novel therapeutic strategies for epithelial ovarian cancer
    Nobuhisa Yoshikawa · 2016 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  85. Visual Analytics Methods for Analyzing Molecular Dynamics Simulations of Mutant Proteins
    Dennis Bromley · 2015 · ResearchWorks at the University of Washington (University of Washington)
  86. Pharmacological characterization and functional rescue of the giant panda and human melanocortin-4 receptors
    Wei Wang · 2017
  87. An investigation of mutant p53 function.
    Jacqueline E. Noll · 2011 · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
  88. Role of Cell Cycle Control, Checkpoints and DNA Repair Mechanisms in Stem Cells and Changes with Aging and Cancerogenesis
    Andreas Brown, Hartmut Geiger · 2017 · Springer eBooks
  89. D EMOGRAPHIC CHARACTERISTICS OF BASAL CEL L CARCINOMA: A RETROSPECTIVE STUDY OF 1884 LESIONS
    Goran Stevanović, Irena Janković, Jadranka Paravina, Dimitrije Janković, Milena Veličković · 2017 · Acta Medica Medianae
  90. Gain-of-function and dominant-negative effects of distinct p53 mutations in lung tumours
    Frances K. Turrell · 2018 · Apollo (University of Cambridge)
  91. Understanding p53 structure and targeting mutant p53 for improved cancer therapy
    Qiang Zhang · 2018 · Figshare
  92. Making sense from nonsense and missense : pharmacological rescue of mutant tumor suppressor p53
    Meiqiongzi Zhang · 2018 · Figshare
  93. Transplantation for TP53 mutant MDS: Room for improvement
    Dries Deeren · 2018 · Leukemia Research
  94. As vias de p53/ARF e interferon beta como alvos de terapia gênica de carcinoma colorretal
    Paulo Roberto Del Valle · 2019
  95. Secreção de Gaussia luciferase como indicador de atividade de caspase-3/7 em resposta ao tratamento com AdCDKN2AIRESp53 em glioblastoma multiforme.
    Daniel Vieira Conde Oliveira · 2018
  96. Change in mutation frequency at a TP53 hotspot during culture of ENU-mutagenised human lymphoblastoid cells
    Masahiko Watanabe, Masae Toudou, Taeko Uchida, Misato Yoshikawa, Hiroaki Aso, Katsuya Suemaru · 2019 · Mutagenesis
  97. Increasing Chemosensitivity in Colorectal Cancer
    Lauren Alicia Agro · 2019 · TSpace (University of Toronto)
  98. OVER KANSERİ HÜCRELERİNDE PRİMA-1 Met TEDAVİSİNE YANIT OLARAK DEĞİŞEN miRNA EKSPRESYON ANALİZİ
    Nilüfer İmir, Esra Arslan Aydemir, Ece Şimşek · 2020 · Sağlık Bilimleri Dergisi
  99. Promising agents on the horizon
    Alice Soragni, Meghna S. Trivedi · 2020 · Elsevier eBooks
  100. Oncogenic alterations in the p53 pathway abolish oscillatory competence
    Lingyun Xiong, Alan Garfinkel · 2021 · bioRxiv (Cold Spring Harbor Laboratory)